Southern Cross Acquisition I Corp.

(Incorporated in the Cayman Islands) We are a newly organized blank check company. We intend to focus our search for an acquisition target on businesses with industry leadership and long-term revenue visibility. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. Because of our significant ties […]

July 15, 2026 Read More

Churchill Capital XIII

(Incorporated in the Cayman Islands) We are a newly organized blank check company backed by Michael Klein, the former Citibank executive and dealmaker. He made his name at Citi and Salomon. He is the founder and managing partner of M. Klein and Company. This SPAC has not chosen a target industry or sector. Michael Klein […]

Read More

Braveheart Bio

(Incorporated in Delaware) We are a clinical-stage biopharmaceutical company whose leading drug candidate, BHB-1893, is being evaluated to treat patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. HCM is a chronic, progressive disease characterized by abnormal thickening and impaired relaxation of the heart. HCM is associated with significant morbidity, reduced quality of life, […]

Read More

Sin Lian Seng Construction

(Incorporated in the Cayman Islands)  We are a Singapore-based supplier of fasteners and a distributor of solar power systems.  We supply nuts, bolts and other industrial fastener products to customers in the construction industry as well as to those in the mechanical and electrical, maritime and manufacturing sectors. We bought Lumenx Energy in June 2025. […]

Read More

Attovia Therapeutics

(Incorporated in Delaware)  We are a Phase 1 clinical biopharmaceutical company developing next-generation biologics for immune-mediated diseases. We use our ATTOBODY platform, a biparatropic nanobody-based technology licensed from Alamar Biosciences. We have no products on the market. And we have no revenue from product sales.  Our lead drug candidate, ATTO-1310, is an ATTOBODY-based therapeutic that […]

Read More

Apnimed

(Incorporated in Delaware) We are a Phase 3 pharmaceutical company developing an oral medication to treat obstructive sleep apnea.  Our only clinical drug candidate, AD109, also known as Oxnimbi, is an anti-apneic neuromuscular modulator in a fixed-dose formulation to treat obstructive sleep apnea. AD109 is a combination of a novel anti-muscarinic and a selective norepinephrine […]

July 14, 2026 Read More

Holtec Nuclear (Withdrawn)

Note: Holtec Nuclear Corp. withdrew its plans for its IPO in a letter to the SEC on Sept. 25, 2026. Holtec Nuclear had postponed its large IPO on Wednesday evening, Sept. 16, 2026 – due to market conditions – following the stock market’s slide. Holtec Nuclear’s deal had been expected to price on Thursday night, […]

Read More

Jones Ventures INTL Acquisition 1 Corp.

(Incorporated in the Cayman Islands) We are a blank check company, incorporated in 2021. We expect to focus on a target in an industry where we believe our management team’s and our affiliates’ expertise will provide us with a competitive advantage, including emerging industries, industrial technology, financial services, digital assets, real estate services and software.  […]

Read More

Material Resource Acquisition Corp.

(Incorporated in the Cayman Islands) We are a newly organized blank check company. We intend to focus on minerals and the material supply chain, including the exploration, mining, processing, refining, producing, equipment, financing and enabling technology. We will consider companies developing advanced or new technologies aimed at improving the efficiency, productivity, environmental performance or economics […]

July 13, 2026 Read More

YPF Energia Electrica S.A. (Dual Listing)

(Incorporated in Argentina) We are the leading pure-play power generation company in Argentina based on installed capacity, engaged in the development and operation of electricity power plants and the generation and commercialization of electricity using both thermal and renewable technologies. We own and operate 17 power generation assets with a total installed capacity of 3,764 […]

Read More